Baker Bros. Advisors LP Protara Therapeutics, Inc. Transaction History
Baker Bros. Advisors LP
- $7.52 Billion
- Q2 2024
A detailed history of Baker Bros. Advisors LP transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 536,832 shares of TARA stock, worth $1.01 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
536,832
Previous 199,671
168.86%
Holding current value
$1.01 Million
Previous $800,000
39.5%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding TARA
# of Institutions
43Shares Held
10.4MCall Options Held
25KPut Options Held
12.7K-
Opaleye Management Inc. Boston, MA2.3MShares$4.33 Million1.23% of portfolio
-
Ra Capital Management, L.P. Boston, MA1.9MShares$3.57 Million0.06% of portfolio
-
Stem Point Capital LP New York, NY984KShares$1.85 Million0.6% of portfolio
-
Boxer Capital, LLC San Diego, CA812KShares$1.53 Million0.09% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il665KShares$1.25 Million0.0% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $21.2M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...